Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2026 Earnings Call Transcript May 14, 2026
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.33.
Operator: Ladies and gentlemen, thank you for standing by. Hello, and welcome to the conference call hosted by Dare Bioscience to review the company’s first quarter 2026 financial results and to provide a business update. This call is being recorded. My name is King, and I will be your operator today. With us...
